Mycobacterium Citations List: May, 2016
Literature Citations
1. Design, Synthesis, Antimicrobial Evaluation and Molecular Modeling Study of 1,2,4-Triazole-based 4-thiazolidinones. Ahmed, S., M.F. Zayed, S.M. El-Messery, M.H. Al-Agamy, and H.M. Abdel-Rahman. Molecules, 2016. 21(5): E568. PMID[27144547].
[PubMed]. TB_05_2016.
2. Synthesis, Cytotoxic and Antitubercular Activities of Copper(II) Complexes with Heterocyclic Bases and 3-Hydroxypicolinic acid. Almeida, J.D., I.M. Marzano, M. Pivatto, N.P. Lopes, A.M.D. Ferreira, F.R. Pavan, I.C. Silva, E.C. Pereira-Maia, G. Von Poelhsitz, and W. Guerra. Inorganica Chimica Acta, 2016. 446: p. 87-92. ISI[000374385600011].
[WOS]. TB_05_2016.
3. Combined Genetic and Bioactivity-based Prioritization Leads to the Isolation of an Endophyte-derived Antimycobacterial Compound. Alvin, A., J.A. Kalaitzis, B. Sasia, and B.A. Neilan. Journal of Applied Microbiology, 2016. 120(5): p. 1229-1239. PMID[26785029].
[PubMed]. TB_05_2016.
4. Synthesis and Docking Studies of Pyrazine-thiazolidinone Hybrid Scaffold Targeting Dormant Tuberculosis. Chitre, T.S., K.D. Asgaonkar, P.B. Miniyar, A.B. Dharme, M.A. Arkile, A. Yeware, D. Sarkar, V.M. Khedkar, and P.C. Jha. Bioorganic & Medicinal Chemistry Letters, 2016. 26(9): p. 2224-2228. PMID[27017114].
[PubMed]. TB_05_2016.
5. In Vitro Evaluation of the Cyto-genotoxic Potential of Ruthenium(II) Scar Complexes: A Promising Class of Antituberculosis Agents. De Grandis, R.A., F.A. Resende, M.M. da Silva, F.R. Pavan, A.A. Batista, and E.A. Varanda. Mutation Research-Genetic Toxicology and Environmental Mutagenesis, 2016. 798: p. 11-18. PMID[26994489].
[PubMed]. TB_05_2016.
6. Oxadiazoles Have Butyrate-specific Conditional Activity against Mycobacterium tuberculosis. Early, J.V., A. Casey, M.A. Martinez-Grau, I.C. Gonzalez Valcarcel, M. Vieth, J. Ollinger, M.A. Bailey, T. Alling, M. Files, Y. Ovechkina, and T. Parish. Antimicrobial Agents and Chemotherapy, 2016. 60(6): p. 3608-3616. PMID[27044545].
[PubMed]. TB_05_2016.
7. Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines that Targets Persistent, Antibiotic-tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
Garrison, A.T., Y. Abouelhassan, V.M. Norwood, D. Kallifidas, F. Bai, T. Nguyen, M. Rolfe, G.M. Burch, S. Jin, H. Luesch, and R.W. Huigens. Journal of Medicinal Chemistry, 2016. 59(8): p. 3808-3825. PMID[27018907].
[PubMed]. TB_05_2016.
8. G1-4A, a Polysaccharide from Tinospora cordifolia Inhibits the Survival of Mycobacterium tuberculosis by Modulating Host Immune Responses in TLR4 Dependent Manner. Gupta, P.K., P. Chakraborty, S. Kumar, P.K. Singh, M.G. Rajan, K.B. Sainis, and S. Kulkarni. Plos One, 2016. 11(5): p. e0154725. PMID[27148868].
[PubMed]. TB_05_2016.
9. Ebselen and Analogs as Inhibitors of Bacillus anthracis Thioredoxin Reductase and Bactericidal Antibacterials Targeting Bacillus Species, Staphylococcus aureus and Mycobacterium tuberculosis. Gustafsson, T.N., H. Osman, J. Werngren, S. Hoffner, L. Engman, and A. Holmgren. Biochimica Et Biophysica Acta-General Subjects, 2016. 1860(6): p. 1265-1271. PMID[26971857].
[PubMed]. TB_05_2016.
10. Activity of Nitazoxanide and Tizoxanide against Mycobacterium tuberculosis in Vitro and in Whole Blood Culture. Harausz, E.P., K.A. Chervenak, C.E. Good, M.R. Jacobs, R.S. Wallis, M. Sanchez-Felix, and W.H. Boom. Tuberculosis, 2016. 98: p. 92-96. PMID[27156623]. PMCID[PMC4864490].
[PubMed]. TB_05_2016.
11. Synthesis, Antimycobacterial and Antibacterial Activity of 1-(6-Amino-3,5-difluoropyridin-2-yl) fluoroquinolone Derivatives Containing an Oxime Functional Moiety. Huang, J., M.H. Wang, B. Wang, Z.Y. Wu, M.L. Liu, L.S. Feng, J. Zhang, X.N. Li, Y. Yang, and Y. Lu. Bioorganic & Medicinal Chemistry Letters, 2016. 26(9): p. 2262-2267. PMID[27020299].
[PubMed]. TB_05_2016.
12. Routes of Synthesis of Carbapenems for Optimizing both the Inactivation of l,d-Transpeptidase LdtMt1 of Mycobacterium tuberculosis and the Stability toward Hydrolysis by beta-Lactamase BlaC. Iannazzo, L., D. Soroka, S. Triboulet, M. Fonvielle, F. Compain, V. Dubee, J.L. Mainardi, J.E. Hugonnet, E. Braud, M. Arthur, and M. Etheve-Quelquejeu. Journal of Medicinal Chemistry, 2016. 59(7): p. 3427-3438. PMID[26937999].
[PubMed]. TB_05_2016.
13. Synthesis and Evaluation of the 2-Aminothiazoles as Anti-tubercular Agents. Kesicki, E.A., M.A. Bailey, Y. Ovechkina, J.V. Early, T. Alling, J. Bowman, E.S. Zuniga, S. Dalai, N. Kumar, T. Masquelin, P.A. Hipskind, J.O. Odingo, and T. Parish. Plos One, 2016. 11(5): p. e0155209. PMID[27171280].
[PubMed]. TB_05_2016.
14. Development and Validation of a Highly Sensitive LC-MS/MS-ESI Method for Quantification of IIIM-019-A Novel Nitroimidazole Derivative with Promising Action against Tuberculosis: Application to Drug Development. Kour, G., B.K. Chandan, M. Khullar, G. Munagala, P.P. Singh, A. Bhagat, A.P. Gupta, R.A. Vishwakarma, and Z. Ahmed. Journal Pharmaceutical Biomedical Analysis, 2016. 124: p. 26-33. PMID[26922579].
[PubMed]. TB_05_2016.
15. Design, Synthesis, and Characterization of Some Hybridized Pyrazolone Pharmacophore Analogs against Mycobacterium tuberculosis. Krishnasamy, S.K., V. Namasivayam, S. Mathew, R.S. Eakambaram, I.A. Ibrahim, A. Natarajan, and S. Palaniappan. Archiv der Pharmazie, 2016. 349(5): p. 383-397. PMID[27135906].
[PubMed]. TB_05_2016.
16. Constituents of Fagraea fragrans with Antimycobacterial Activity in Combination with Erythromycin. Madmanang, S., N. Cheyeng, S. Heembenmad, W. Mahabusarakam, J. Saising, M. Seeger, S. Chusri, and S. Chakthong. Journal of Natural Products, 2016. 79(4): p. 767-774. PMID[26905094].
[PubMed]. TB_05_2016.
17. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition. Mehra, R., V.S. Rajput, M. Gupta, R. Chib, A. Kumar, P. Wazir, I.A. Khan, and A. Nargotra. Journal of Chemical Information and Modeling, 2016. 56(5): p. 930-940. PMID[27149193].
[PubMed]. TB_05_2016.
18. Synthesis and Antitubercular and Antibacterial Activity of Some Active Fluorine Containing Quinoline-pyrazole Hybrid Derivatives. Nayak, N., J. Ramprasad, and U. Dalimba. Journal of Fluorine Chemistry, 2016. 183: p. 59-68. ISI[000374607900008].
[WOS]. TB_05_2016.
19. Synthesis and Antimycobacterial Screening of New N-(4-(5-Aryl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl)phenyl)-4 -amide Derivatives. Nayak, N., J. Ramprasad, U. Dalimba, P. Yogeeswari, and D. Sriram. Chinese Chemical Letters, 2016. 27(3): p. 365-369. ISI[000374799400014].
[WOS]. TB_05_2016.
20. Anti-mycobacterium tuberculosis Activity of Calophyllum brasiliense Extracts Obtained by Supercritical Fluid Extraction and Conventional Techniques. Pires, C.T.A., R.B.D. Scodro, M.A. Brenzan, D.A.G. Cortez, V.L.D. Siqueira, L. Cardozo, R.M. Goncalves, K.R. Caleffi-Ferracioli, and R.F. Cardoso. Current Pharmaceutical Biotechnology, 2016. 17(6): p. 532-539. PMID[26778457].
[PubMed]. TB_05_2016.
21. Synthesis and Antitubercular Activity of 1,2,4-Trisubstitued Piperazines. Rohde, K.H., H.A. Michaels, and A. Nefzi. Bioorganic & Medicinal Chemistry Letters, 2016. 26(9): p. 2206-2209. PMID[27020522].
[PubMed]. TB_05_2016.
22. Design and Synthesis of Novel Quinoxaline Derivatives as Potential Candidates for Treatment of Multidrug-resistant and Latent Tuberculosis. Santivanez-Veliz, M., S. Perez-Silanes, E. Torres, and E. Moreno-Viguri. Bioorganic & Medicinal Chemistry Letters, 2016. 26(9): p. 2188-2193. PMID[27025343]. PMCID[PMC4856737].
[PubMed]. TB_05_2016.
23. Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters. Sasabe, H., Y. Shimokawa, M. Shibata, K. Hashizume, Y. Hamasako, Y. Ohzone, E. Kashiyama, and K. Umehara. Antimicrobial Agents and Chemotherapy, 2016. 60(6): p. 3497-3508. PMID[27021329].
[PubMed]. TB_05_2016.
24. In Vitro Activity of Copper(II) Complexes, Loaded or Unloaded into a Nanostructured Lipid System, against Mycobacterium tuberculosis. Silva, P.B., P.C. Souza, G.M. Calixto, O. Lopes Ede, R.C. Frem, A.V. Netto, A.E. Mauro, F.R. Pavan, and M. Chorilli. International Journal of Molecular Sciences, 2016. 17(5). PMID[27196901]. PMCID[PMC4881567].
[PubMed]. TB_05_2016.
25. MIC of Delamanid (OPC-67683) against Mycobacterium tuberculosis Clinical Isolates and a Proposed Critical Concentration. Stinson, K., N. Kurepina, A. Venter, M. Fujiwara, M. Kawasaki, J. Timm, E. Shashkina, B.N. Kreiswirth, Y. Liu, M. Matsumoto, and L. Geiter. Antimicrobial Agents and Chemotherapy, 2016. 60(6): p. 3316-3322. PMID[26976868].
[PubMed]. TB_05_2016.
26. Antimicrobial Compounds from Endophytic Streptomyces sp. BCC72023 Isolated from Rice (Oryza sativa L.). Supong, K., C. Thawai, W. Choowong, C. Kittiwongwattana, D. Thanaboripat, C. Laosinwattana, P. Koohakan, N. Parinthawong, and P. Pittayakhajonwut. Research in Microbiology, 2016. 167(4): p. 290-298. PMID[26809052].
[PubMed]. TB_05_2016.
27. Triazolophthalazines: Easily Accessible Compounds with Potent Antitubercular Activity. Veau, D., S. Krykun, G. Mori, B.S. Orena, M.R. Pasca, C. Frongia, V. Lobjois, S. Chassaing, C. Lherbet, and M. Baltas. ChemMedChem, 2016. 11(10): p. 1078-1089. PMID[27097919].
[PubMed]. TB_05_2016.
28. Neuroleptic Drugs in the Treatment of Tuberculosis: Minimal Inhibitory Concentrations of Different Phenothiazines against Mycobacterium tuberculosis. Vesenbeckh, S., D. Krieger, G. Bettermann, N. Schonfeld, T.T. Bauer, H. Russmann, and H. Mauch. Tuberculosis, 2016. 98: p. 27-29. PMID[27156615].
[PubMed]. TB_05_2016.
Patent Citations
29. Preparation of Pyrimidoindolyl Compounds with Activity against Bacteria and Mycobacteria. Cooper, I., M. Pichowicz, and N. Stokes. Patent. 2016. 2015-GB53212 2016067009: 63pp.
[Patent]. TB_05_2016.
30. Multi-drug Therapies for Tuberculosis Treatment. Ho, C.-M., D.L. Clemens, B.-Y.L. Clemens, M.A. Horwitz, A.M. Silva Vite, T. Kee, and X. Ding. Patent. 2016. 2015-US58892 2016073524: 80pp.
[Patent]. TB_05_2016.